ArticleCancer chemotherapy and pharmacology2022

Risk factors of proteinuria and potentially protective effect of renin-angiotensin system inhibitors in patients with renal cell carcinoma receiving axitinib.

Hiroaki Ikesue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.